drugset / Trial / NCT00902993

Study to Investigate Safety, Tolerability and Pharmacokinetics With Single and Multiple Ascending Doses of AZD1446

NCT00902993

Phase 1 Completed 80 enrolled AstraZeneca
RandomizedParallel-groupTriple-blindBasic science

Summary

This study is designed to evaluate the safety, tolerability and PK of AZD1446 in Subjects when given as multiple dose administration for either 7 Days (Day 1 single dose, Day 2-6 multiple doses) in Part A and optionally at fractionated doses for 1 Day in Part B.

Timeline

Start
2009-04
Primary completion
Completion
2009-09

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD1446 Small molecule Oral

Indications

No indication recorded.